415 related articles for article (PubMed ID: 8570149)
1. Cytomegalovirus optic neuritis: characteristics, therapy and survival.
Mansor AM; Li HK
Ophthalmologica; 1995; 209(5):260-6. PubMed ID: 8570149
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus optic neuritis.
Mansour AM
Curr Opin Ophthalmol; 1997 Jun; 8(3):55-8. PubMed ID: 10168894
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus papillitis in patients with acquired immune deficiency syndrome. Visual prognosis of patients treated with ganciclovir and/or foscarnet.
Patel SS; Rutzen AR; Marx JL; Thach AB; Chong LP; Rao NA
Ophthalmology; 1996 Sep; 103(9):1476-82. PubMed ID: 8841309
[TBL] [Abstract][Full Text] [Related]
4. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
[TBL] [Abstract][Full Text] [Related]
5. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
Ophthalmology; 1994 Jul; 101(7):1250-61. PubMed ID: 8035989
[TBL] [Abstract][Full Text] [Related]
6. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
Arevalo JF; Garcia RA; Mendoza AJ
Eur J Ophthalmol; 2005; 15(5):610-8. PubMed ID: 16167292
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis.
Flores-Aguilar M; Kuppermann BD; Quiceno JI; Dankner WM; Wolf DG; Capparelli EV; Connor JD; Sherwood CH; Fullerton S; Gambertoglio JG
Ophthalmology; 1993 Jul; 100(7):1022-31. PubMed ID: 8391674
[TBL] [Abstract][Full Text] [Related]
8. High-dose (2000-microgram) intravitreous ganciclovir in the treatment of cytomegalovirus retinitis.
Young S; Morlet N; Besen G; Wiley CA; Jones P; Gold J; Li Y; Freeman WR; Coroneo MT
Ophthalmology; 1998 Aug; 105(8):1404-10. PubMed ID: 9709750
[TBL] [Abstract][Full Text] [Related]
9. 2.5 years survival with sequential ganciclovir/foscarnet treatment in a patient with acquired immune deficiency syndrome and cytomegalovirus retinitis.
Geier SA; Klauss V; Matuschke A; Kronawitter U; Goebel FD
Ger J Ophthalmol; 1992; 1(2):110-3. PubMed ID: 1335812
[TBL] [Abstract][Full Text] [Related]
10. Use of the ganciclovir implant in the treatment of recurrent cytomegalovirus retinitis.
Marx JL; Kapusta MA; Patel SS; LaBree LD; Walonker F; Rao NA; Chong LP
Arch Ophthalmol; 1996 Jul; 114(7):815-20. PubMed ID: 8660164
[TBL] [Abstract][Full Text] [Related]
11. The progressive outer retinal necrosis syndrome: successful treatment with combination antiviral therapy.
Ciulla TA; Rutledge BK; Morley MG; Duker JS
Ophthalmic Surg Lasers; 1998 Mar; 29(3):198-206. PubMed ID: 9547773
[TBL] [Abstract][Full Text] [Related]
12. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial.
Martin DF; Parks DJ; Mellow SD; Ferris FL; Walton RC; Remaley NA; Chew EY; Ashton P; Davis MD; Nussenblatt RB
Arch Ophthalmol; 1994 Dec; 112(12):1531-9. PubMed ID: 7993207
[TBL] [Abstract][Full Text] [Related]
13. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
Am J Ophthalmol; 1997 Aug; 124(2):141-57. PubMed ID: 9262538
[TBL] [Abstract][Full Text] [Related]
14. Treatment of relapsed cytomegalovirus retinitis with the sustained-release ganciclovir implant.
Hatton MP; Duker JS; Reichel E; Morley MG; Puliafito CA
Retina; 1998; 18(1):50-5. PubMed ID: 9502281
[TBL] [Abstract][Full Text] [Related]
15. Treatment of bilateral cytomegalovirus retinitis with sustained-release ganciclovir implants in a child.
Malley DS; Barone R; Heinemann MH
Am J Ophthalmol; 1996 Nov; 122(5):731-2. PubMed ID: 8909217
[TBL] [Abstract][Full Text] [Related]
16. Long-term visual morbidity of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
Roarty JD; Fisher EJ; Nussbaum JJ
Ophthalmology; 1993 Nov; 100(11):1685-8. PubMed ID: 8233395
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal ganciclovir for cytomegalovirus retinitis in patients with AIDS.
Montero MC; Pastor M; Buenestado C; Lluch A; Atienza M
Ann Pharmacother; 1996; 30(7-8):717-23. PubMed ID: 8826547
[TBL] [Abstract][Full Text] [Related]
18. Treatment of cytomegalovirus retinitis in acquired immunodeficiency syndrome with intravitreal ganciclovir implant.
Tayanithi P
J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S142-7. PubMed ID: 11529327
[TBL] [Abstract][Full Text] [Related]
19. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
Walton RC; Whitcup SM; Mueller BU; Lewis LL; Pizzo PA; Nussenblatt RB
Ophthalmology; 1995 Dec; 102(12):1865-70. PubMed ID: 9098289
[TBL] [Abstract][Full Text] [Related]
20. Juxtapapillary cytomegalovirus retinitis with optic neuritis.
Ioannidis AS; Bacon J; Frith P
J Neuroophthalmol; 2008 Jun; 28(2):128-30. PubMed ID: 18562846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
